Paper · 20229

Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted.

Matzinger P and 1 other. Cell Immunol, 1977. Cited by 90 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Papers, record 20229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20229

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted.; PubMed
Journal: Cell Immunol; PubMed
Year: 1977; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/20229/; PubMed
DOI: https://doi.org/10.1016/0008-8749(77)90137-x; PubMed
The journal: https://conductscience.org/library/journal-index/1246405; PubMed
Citations, by iCite: 90; iCite
Relative citation ratio, by iCite: 1.33; iCite
Revised in PubMed: 2019-07-20; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Matzinger P	P
2	Bevan MJ	M J

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Cytotoxicity, Immunologic	Major topic
Histocompatibility Antigens	Major topic
T-Lymphocytes	Major topic
Animals
Cross Reactions
Graft vs Host Reaction
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred Strains

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMID	Title	Journal	Year	In Papers	Source
39,743,230	Mechanisms of allorecognition and xenorecognition in transplantation.	Clin Transplant Res	2024	https://conductscience.org/library/papers/39743230	PubMed
36,645,993	The evolving biology of cross-presentation.	Semin Immunol	2023	https://conductscience.org/library/papers/36645993	PubMed
35,543,702	DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.	J Exp Med	2022	https://conductscience.org/library/papers/35543702	PubMed
28,191,593	Learning from a contemporary history of immunology.	Immunol Res	2017	https://conductscience.org/library/papers/28191593	PubMed
25,980,325	A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.	J Neuroimmune Pharmacol	2015	https://conductscience.org/library/papers/25980325	PubMed
24,687,086	Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.	Blood	2014	https://conductscience.org/library/papers/24687086	PubMed
24,296,490	HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.	Biol Blood Marrow Transplant	2014	https://conductscience.org/library/papers/24296490	PubMed
21,668,313	Immune recognition and rejection of allogeneic skin grafts.	Immunotherapy	2011	https://conductscience.org/library/papers/21668313	PubMed
12,952,297	The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors.	J Neurooncol	2003	https://conductscience.org/library/papers/12952297	PubMed
12,522,443	Principles of tumor immunosurveillance and implications for immunotherapy.	Cancer Gene Ther	2002	https://conductscience.org/library/papers/12522443	PubMed

1 to 10 of 26

See all 26 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20229

GET https://conductscience.org/api/papers/v1/20229/cited_by?page=2

API reference For AI assistants